CPHI
CHINA PHARMA HOLDINGS, INC.Company Information
- Company Name
- CHINA PHARMA HOLDINGS, INC.
- CIK
- CIK0001106644
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CPHI: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CPHI
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 203,802
- Shares outstanding
- 40,522,002
- Ownership
- 0.50%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -27.43%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | - | - | - | - | - | - | - | 0 | 1 | 1 | 1 | ||||||
Assets | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
Assets Current | |||||||||||||||||
| Assets Current | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 6 | 6 | ||||||
| Assets Held In Trust Current | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 8 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 38 | 39 | 24 | 9 | 6 | 7 | 7 | 4 | 4 | 3 | 2 | ||||||
| Assets | 45 | 45 | 31 | 16 | 14 | 14 | 15 | 13 | 14 | 16 | 15 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||
| Accounts Payable Trade Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | ||||||
| Accrued Liabilities Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Other Current | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | |||||||||||||||||
| Liabilities Current | 8 | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 7 | 7 | ||||||
| Short Term Borrowings | 2 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Lines Of Credit Current | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | 0 | 0 | 1 | 2 | ||||||
| Long Term Line Of Credit | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Noncurrent | |||||||||||||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | - | - | - | - | - | 0 | 0 | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 9 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 9 | 9 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | |||||||||||||||||
| Additional Paid In Capital | 74 | 74 | 59 | 43 | 41 | 41 | 41 | 38 | 38 | 35 | 33 | ||||||
| Stockholders Equity | 36 | 37 | 23 | 8 | 6 | 7 | 8 | 7 | 7 | 7 | 6 | ||||||
| Stockholders Equity Note Subscriptions Receivable | -0 | -0 | -0 | -0 | -0 | -0 | -0 | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -50 | -48 | -47 | -46 | -45 | -45 | -44 | -43 | -42 | -39 | -38 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 13 | 12 | 12 | 11 | 11 | 11 | 11 | 12 | 11 | 11 | 11 | ||||||
| Liabilities And Stockholders Equity | 45 | 45 | 31 | 16 | 14 | 14 | 15 | 13 | 14 | 16 | 15 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 14 | 14 | 14 | 14 | 14 | 14 | 16 | ||||||
| Allowance For Notes And Loans Receivable Current | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 41 | 41 | 16 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | ||||||
| Shares Outstanding | 41 | 41 | 16 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCHINA PHARMA HOLDINGS, INC. (CPHI) — SEC Financial Statements & Analysis
CHINA PHARMA HOLDINGS, INC. (CPHI) is a pharmaceutical preparations company, incorporated in DE. CHINA PHARMA HOLDINGS, INC. trades on NYSE as: CPHI. CHINA PHARMA HOLDINGS, INC. (CPHI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, CHINA PHARMA HOLDINGS, INC. carries a market cap of $26.74M, a P/E ratio of -5.98x, a P/B ratio of 0.74x, a P/S ratio of 6.83x, an enterprise value of $30.04M, and an EV/EBITDA multiple of -20.84x. On profitability, it posts a gross margin of 11.76%, an operating margin of -111.84%, a net margin of -114.33%, a Return on Equity (ROE) of -20.99%, a Return on Assets (ROA) of -15.30%, and a Return on Invested Capital (ROIC) of -18.39%. Per share, it reports EPS of $-0.11, diluted EPS of $-0.11, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -32.12% year-over-year, net income growth of -2.98% year-over-year, and EPS growth of -92.28% year-over-year. On the balance sheet, it maintains a current ratio of 0.26x, a quick ratio of 0.07x, working capital of $-5.67M, a debt-to-equity ratio of 0.24x, a debt ratio of 0.19, an interest coverage ratio of -83.56x, free cash flow of $-141.56K (TTM), and net debt of $3.30M. Figures sourced from SEC EDGAR.
- Market Cap
- $26.74M
- P/E TTM
- -5.98x
- EPS TTM
- $-0.11
- P/B TTM
- 0.74x
- ROE TTM
- -20.99%
- ROA TTM
- -15.30%
- Debt To Equity
- 0.24x
- Free Cash Flow TTM
- $-141.56K
- Net Revenue TTM Growth 1Y
- -32.12%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CHINA PHARMA HOLDINGS, INC. in?
CHINA PHARMA HOLDINGS, INC. (CPHI) operates in the Pharmaceutical Preparations industry.
What exchange does CPHI trade on?
CHINA PHARMA HOLDINGS, INC. (CPHI) trades on the NYSE.
Where is CHINA PHARMA HOLDINGS, INC. incorporated?
CHINA PHARMA HOLDINGS, INC. is incorporated in DE.
When was CHINA PHARMA HOLDINGS, INC. (CPHI)'s most recent SEC filing?
CHINA PHARMA HOLDINGS, INC. (CPHI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is CPHI's market cap?
CHINA PHARMA HOLDINGS, INC. (CPHI) has a market capitalization of $26.74M as of 2026-06-30.
What is CPHI's EPS (earnings per share)?
CHINA PHARMA HOLDINGS, INC. (CPHI)'s trailing twelve month EPS is $-0.11 as of 2026-06-30.
What is CPHI's ROE (return on equity)?
CHINA PHARMA HOLDINGS, INC. (CPHI)'s trailing twelve month Return on Equity (ROE) is -20.99% as of 2026-06-30.
What is CPHI's ROA (return on assets)?
CHINA PHARMA HOLDINGS, INC. (CPHI)'s trailing twelve month Return on Assets (ROA) is -15.30% as of 2026-06-30.
What is CPHI's ROIC (return on invested capital)?
CHINA PHARMA HOLDINGS, INC. (CPHI)'s trailing twelve month Return on Invested Capital (ROIC) is -18.39% as of 2026-06-30.
What is CPHI's EV/EBITDA?
CHINA PHARMA HOLDINGS, INC. (CPHI)'s trailing twelve month EV/EBITDA is -20.84x as of 2026-06-30.